| Zugriffsnummer | 40284 |
| Dokumenttyp | Zeitschriftenartikel |
| Sprache | Englisch |
| Titel | Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project |
| Autor(in); Institution |
Winterer, G.; Experimental and Clinical Research Center (ECRC), Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Pharmaimage Biomarker Solutions GmbH, Berlin, GERMANY
Androsova, G.; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, LUXEMBOURG
Bender, O.; Koordinierungszentrum Klinische Studien (KKS), Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Boraschi, D.; Institute of Protein Biochemistry, Consiglio Nazionale delle Ricerche (CNR) di Pisa, Pisa, ITALY
Borchers, F.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Dschietzig, T. B.; Immundiagnostik AG, Bensheim, GERMANY
Feinkohl, I.; Molecular Epidemiology, Max-Delbrück Center (MDC), Berlin, GERMANY
Fletcher, P.; Behavioural and Clinical Neurosciences Institute, Department of Medicine, University of Cambridge, Cambridge, UK
Gallinat, J.; Department of Psychiatry, University of Hamburg, Hamburg, GERMANY
Hadzidiakos, D.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Haynes, J. D.; Berlin Center for Advanced Neuroimaging (BCAN), Berlin, GERMANY
Heppner, F.; Institute of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Hetzer, S.; Berlin Center for Advanced Neuroimaging (BCAN), Berlin, GERMANY
Hendrikse, J.; Department of Radiology and Brain Center Rudolf Magnus, University Medical Center Utrecht (UMC), Utrecht, THE NETHERLANDS
Ittermann, Bernd; 8.1, Biomedizinische Magnetresonanz, PTB-Berlin
Kant, I. M J.; Department of Intensive Care Medicine and Brain Center Rudolf Magnus, University Medical Center Utrecht (UMC), Utrecht, THE NETHERLANDS
Kraft, A.; Berlin Institute of Health (BIH), Berlin, GERMANY
Krannich, A.; Berlin Institute of Health (BIH), Berlin, GERMANY
Krause, R.; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, LUXEMBOURG
Kühn, S.; Pharmaimage Biomarker Solutions GmbH, Berlin, GERMANY; Behavioural and Clinical Neurosciences Institute, Department of Medicine, University of Cambridge, Cambridge, UK; Max-Planck Inst. for Human Development, Berlin, GERMANY
Lachmann, G.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
van Montfort, S. J. T.; Department of Intensive Care Medicine and Brain Center Rudolf Magnus, University Medical Center Utrecht (UMC), Utrecht, THE NETHERLANDS
Müller, A.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Nürnberg, P.; Atlas Biolabs GmbH, Berlin, Germany; Cologne Center for Genomics (CCG), University of Cologne, Cologne, GERMANY
Ofosu, K.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Pietsch, M.; Cellogic GmbH (Cellogic), Berlin, GERMANY
Pischon, T.; Molecular Epidemiology, Max-Delbrück Center (MDC), Berlin, GERMANY
Preller, J.; Department of Anesthesiology, Cambridge University Hospitals NHS Foundation Trust (CUH), Cambridge, UK
Renzulli, E.; ALTA Ricerca e Sviluppo in Bioecnologie Srlu (ALTA), Siena, ITALY
Scheurer, K.; Experimental and Clinical Research Center (ECRC), Charité - Universitätsmedizin Berlin, Berlin, GERMANY; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Schneider, R.; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, LUXEMBOURG
Slooter, A. J. C.; Department of Intensive Care Medicine and Brain Center Rudolf Magnus, University Medical Center Utrecht (UMC), Utrecht, THE NETHERLANDS
Spies, C.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Stamatakis, E.; Behavioural and Clinical Neurosciences Institute, Department of Medicine, University of Cambridge, Cambridge, UK
Volk, H. D.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Weber, S.; Cellogic GmbH (Cellogic), Berlin, GERMANY
Wolf, A.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Yürek, F.; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, GERMANY
Zacharias, N.; Experimental and Clinical Research Center (ECRC), Charté - Universitätsmedizin Berlin, Berlin, GERMANY; Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Pharmaimage Biomarker Solutions GmbH, Berlin, GERMANY
|
| Quelle/Jahr | European Psychiatry: 50 (2018), 34 - 39 |
| ISSN | 0924-9338 (PRINT) ; 1778-3585 (ONLINE) |
| DOI | |
| Verlag | Amsterdam [u.a.]: Elsevier |
| Freie Schlagworte | Molecular biomarkers ; Multivariate prediction algorithm ; Neuroimaging ; Postoperative cognitive dysfunction ; Postoperative delirium |
| Zusammenfassung | Postoperative cognitive impairment is among the most common medical complications associated with surgical interventions – particularly in elderly patients. In our aging society, it is an urgent medical need to determine preoperative individual risk prediction to allow more accurate cost–benefit decisions prior to elective surgeries. So far, risk prediction is mainly based on clinical parameters. However, these parameters only give a rough estimate of the individual risk. At present, there are no molecular or neuroimaging biomarkers available to improve risk prediction and little is known about the etiology and pathophysiology of this clinical condition. In this short review, we summarize the current state of knowledge and briefly present the recently started BioCog project (Biomarker Development for Postoperative Cognitive Impairment in the Elderly), which is funded by the European Union. It is the goal of this research and development (R&D) project, which involves academic and industry partners throughout Europe, to deliver a multivariate algorithm based on clinical assessments as well as molecular and neuroimaging biomarkers to overcome the currently unsatisfying situation. |
Zitierung
Winterer, G., Androsova, G., Bender, O., Boraschi, D., Borchers, F., Dschietzig, T. B., Feinkohl, I., Fletcher, P., Gallinat, J., Hadzidiakos, D., Haynes, J. D., Heppner, F., Hetzer, S., Hendrikse, J., Ittermann, B., Kant, I. M. J., Kraft, A., Krannich, A., Krause, R., Kühn, S., Lachmann, G., van Montfort, S. J. T., Müller, A., Nürnberg, P., Ofosu, K., Pietsch, M., Pischon, T., Preller, J., Renzulli, E., Scheurer, K., Schneider, R., Slooter, A. J. C., Spies, C., Stamatakis, E., Volk, H. D., Weber, S., Wolf, A., Yürek, F., & Zacharias, N. (2018). Personalized risk prediction of postoperative cognitive impairment - rationale for the EU-funded BioCog project. European Psychiatry, 50, 34–39. https://doi.org/10.1016/j.eurpsy.2017.10.004